Author's posts
UnitedHealth loses Medicare Advantage overpayment argument on appeal
UnitedHealthcare has lost its argument over Medicare Advantage overpayments.
On Aug. 13, the United States Court of Appeals for the District of Columbia ruled against UnitedHealthcare and remanded the case back to the lower court with the instructions …
American Academy of Family Physicians urges FDA to approve EUA for vaccines for young children
The American Academy of Family Physicians is urging the Food and Drug Administration to consider emergency use authorization of COVID-19 vaccines for children under the age of 12.
Currently, vaccines are available for children ages 12 and older.
Pfizer submits data to support a booster dose of its COVID-19 vaccine
Both Pfizer and Moderna have received amended EUAs to give a third shot to individuals with weakened immune systems.
Florida, driven by the unvaccinated, is epicenter of the pandemic
New York Gov. Andrew Cuomo says hospital and long-term care staff will be required to get vaccinated by September 27.
HHS is requiring its healthcare workforce to get vaccinated
The Department of Health and Human Services has become the latest federal agency to mandate vaccinations for its employees.
On Thursday, HHS Secretary Xavier Becerra announced that HHS would require the more than 25,000 members of its healthcare workfo…
Rainn Wilson makes us grateful for being number two
“Grateful people go to the doctor less, and live longer. It’s absolutely a super power,” Wilson told a full house at HIMSS21.
AI is the new paradigm in forecasting infectious disease risk
LAS VEGAS – Optum is using artificial intelligence and machine learning to create infectious disease forecasting that is as accurate as weather forecasting.
Optum researchers first began studying the COVID-19 pandemic while tracking an early flu outbre…
The digital revolution has begun but 52% of executives have not progressed beyond the pilot stage
HIMSS Trust results show a willingness to invest in the future of healthcare.
After 20-year effort, Tom Leary of HIMSS is optimistic for passage of patient identifier
LAS VEGAS – After more than 20 years of working toward the creation of a national patient identifier, Tom Leary, senior vice president of Government Relations for HIMSS, is very optimistic about the chances for success this year, he told those attendin…
Lack of diversity in clinical trials influences drug development
Diversity in clinical trials is lacking, according to Chris Boone, vice president, Global Head of Health Economics and Outcomes Research at Abbvie, a pharmaceutical and research development company.
Less than 16% people of color are in clinical trials,…
